Intelligence Platform
Patents
Browse 222 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 12410430
Modulating apolipoprotein (A) expression
granted patentUS 12410225
Modulation of dendritic cell lineages
granted patentUS 12409188
Modulators of HSD17B13 expression
granted patentUS 12364753
CD8 binding agents
granted patentUS 12350285
Compounds and methods for reducing ATXN3 expression
granted patentUS 12351633
PD-1 and PD-L1 binding agents
granted patentUS 12351614
CLEC9A-based chimeric protein complexes
granted patentUS 12343357
Compositions and methods for modulating MECP2 expression
granted patentUS 12297431
Modulation of huntingtin expression
granted patentUS 12291709
Compositions and methods for modulating apolipoprotein (a) expression
granted patentUS 12281305
Compounds and methods for reducing prion expression
granted patentUS 12275940
Conjugated antisense compounds and their use
granted patentUS 12241067
Compounds and methods for reducing LRRK2 expression
granted patentUS 12227746
Compounds and methods for modulating SCN2A
granted patentUS 12215321
Modulators of diacyglycerol acyltransferase 2 (DGAT2)
granted patentUS 12188020
Methods for reducing Ataxin-2 expression
granted patentUS 12180479
Compounds and methods for modulating ATXN1
granted patentUS 12152244
Selective antisense compounds and uses thereof
granted patentUS 12115225
GLP-1 receptor ligand moiety conjugated oligonucleotides and uses thereof
granted patentUS 12110491
Selective reduction of allelic variants
granted patentUS 12091463
Clec9A binding agents comprising a recombinant heavy-chain only antibody (VHH)
granted patentUS 12084497
SIRP1Ξ± targeted chimeric proteins and uses thereof
granted patentUS 12043831
Modulation of alpha synuclein expression
granted patentUS 12042510
Modulators of IRF4 expression
granted